globalsecuritynewswire.org
An agreement is being finalized for Russia to export medical isotopes to Iran, the Russian state-owned nuclear firm Rosatom announced yesterday (see GSN, Feb. 22).

Israeli President Shimon Peres delivers a speech in Madrid today. Peres said the passage of two Iranian navy ships through the Suez Canal to the Mediterranean Sea showcased the potential threat of a nuclear-armed Iran (Javier Soriano/Getty Images).
A spokesman for the organization did not elaborate on the timing of the anticipated signing, RIA Novosti reported. Tehran’s need for molybdenum 99 and iodine 131 was addressed in talks between Iranian officials and Rosatom head Sergei Kiriyenko (RIA Novosti, Feb. 22).
The deal would involve transfers of each isotope from Russia to Iran every week, Interfax reported.
Under a 2009 bid put forward by the International Atomic Energy Agency, Iran would have exchanged 1,200 kilograms of low-enriched uranium for material to fuel a medical isotope production reactor in Tehran. The Middle Eastern state ultimately rejected the plan worked out with France, Russia and the United States, which was aimed in part at deferring Iran’s ability to produce sufficient weapon material for a bomb long enough to more fully address U.S. and European concerns about Iranian enrichment activities. Tehran has insisted its atomic ambitions are strictly peaceful.
Iran since December has two rounds of talks with Germany and permanent U.N. Security Council member states Read more…
You must be logged in to post a comment.